Target intelligence / Profile preview

Long intergenic non-protein coding RNA 491 (LINC00491)

Target
LINC00491
Molecular classification
Long non-coding RNA, Competing endogenous RNA (ceRNA), Other (non-protein coding RNA)
01

Overview

Long intergenic non-protein coding RNA 491 (LINC00491) is a cytoplasmic long non-coding RNA transcribed from chromosome 5q21.1[1][6]. It is characterized as a competing endogenous RNA (ceRNA) that interacts with and "sponges" specific microRNAs, such as miR-145 in colon adenocarcinoma and miR-324-5p in non-small cell lung cancer, leading to increased expression of oncogenic proteins such as SERPINE1 and SP1[2][4][6]. LINC00491 is significantly upregulated in various cancers and promotes proliferation, migration, and invasion of cancer cells, while its knockdown increases apoptosis and reduces malignant phenotypes[3][5][6]. This molecule is increasingly studied as both a therapeutic target and a prognostic biomarker, though its functions suggest caution for safety given the complexity of lncRNA networks[4][6].

Other names
BC008363CTD-2340E1.3LINC00491
02

Mechanism of action

Acts as a competing endogenous RNA to "sponge" specific microRNAs (e.g., miR-145, miR-324-5p), leading to upregulation of target oncogenes (e.g., SERPINE1, SP1)

03

Biological functions

Cell proliferationCell migrationCell invasionRegulation of apoptosisRegulation of gene expression via microRNA sponging
04

Disease associations

Cancer (notably colon adenocarcinoma, non-small cell lung cancer, esophageal squamous cell carcinoma, endometrial cancer, breast cancer)Prognostic biomarker in cancer
05

Safety considerations

As therapeutic targeting of long non-coding RNAs is still in its early stages, concerns may include off-target effects and delivery specificityUnintended modulation of global RNA regulatory networks and normal cellular gene expression due to broad lncRNA-microRNA interactions
06

Biomarkers

LINC00491 expression levels serve as a prognostic biomarker for several cancers including colon adenocarcinoma and non-small cell lung cancerAssociated downstream proteins such as SERPINE1 and SP1 may also function as molecular markers in relevant cancers

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 491 (LINC00491).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 491 (LINC00491).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call